Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pregabalin × Sarcoma × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Sarcoma 1 Head & Neck 1

Conditions

Pain, Intractable 1 Neoplasms 1 Bone Neoplasms 1

Interventions

Imatinib Mesylate 3 Sunitinib 2 Ibandronic Acid 2 Cyclophosphamide 2 regorafenib 1 nirogacestat 1 nilotinib 1 avapritinib 1 anlotinib 1 Tranexamic Acid 1 Thiotepa 1 Ritonavir 1 Radiotherapy 1 Pregabalin 1 Oxaliplatin 1 Nevirapine 1 Midazolam 1 Lopinavir 1 Lead 1 Kyphoplasty 1 Indocyanine Green 1 Filgrastim 1 Esomeprazole 1 Erlotinib Hydrochloride 1 Enoxaparin 1 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 Emtricitabine 1 Doxorubicin 1 Caffeine 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡